Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,797,682
+$4,374,056 QoQ
Shares Held
649,755
-12.0% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $41,356,581,132 across 16 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,274,243 | $13,522,666,405 | |
| 2 | JNJ |
Johnson & Johnson
|
23,438,141 | $5,952,584,668 | |
| 3 | ABBV |
AbbVie Inc.
|
21,237,764 | $5,344,270,929 | |
| 4 | MRK |
Merck & Co., Inc.
|
30,535,208 | $3,923,774,226 | |
| 5 | AZN |
Astrazeneca PLC
|
17,690,462 | $3,354,465,400 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,649,065 | $2,356,122,869 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,045,352 | $1,961,693,176 | |
| 8 | AMGN |
Amgen Inc
|
5,058,830 | $1,831,903,515 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,797,682 | 649,755 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,423,626 | 738,502 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $12,761,508 | 1,779,848 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,558,147 | 520,426 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $7,176,216 | 741,345 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,017,901 | 1,008,590 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,036,185 | 806,715 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,976,431 | 1,253,342 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,115,238 | 1,309,915 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,647,982 | 1,204,680 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,659,157 | 808,541 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $14,475,337 | 833,833 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,381,690 | 1,027,472 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $32,977,530 | 1,402,106 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $27,269,228 | 976,342 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $30,081,329 | 1,285,527 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,487,824 | 1,466,306 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $53,487,817 | 1,531,286 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $58,531,595 | 1,922,220 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $71,391,532 | 2,177,235 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $76,320,042 | 2,522,143 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||